Harbor Capital Advisors Inc. grew its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 268.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 246,860 shares of the company's stock after purchasing an additional 179,803 shares during the quarter. Harbor Capital Advisors Inc. owned approximately 1.04% of OrthoPediatrics worth $6,692,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. International Assets Investment Management LLC raised its holdings in OrthoPediatrics by 2,610.8% in the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company's stock worth $27,000 after purchasing an additional 966 shares in the last quarter. Quest Partners LLC bought a new position in OrthoPediatrics in the second quarter worth $34,000. EntryPoint Capital LLC raised its holdings in OrthoPediatrics by 56.9% in the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company's stock worth $81,000 after purchasing an additional 1,009 shares in the last quarter. SG Americas Securities LLC bought a new position in OrthoPediatrics in the second quarter worth $110,000. Finally, State Board of Administration of Florida Retirement System bought a new position in OrthoPediatrics in the first quarter worth $178,000. Hedge funds and other institutional investors own 69.05% of the company's stock.
Insider Activity at OrthoPediatrics
In other OrthoPediatrics news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the company's stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $29.30, for a total value of $293,000.00. Following the transaction, the general counsel now owns 77,304 shares of the company's stock, valued at $2,265,007.20. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 31.80% of the stock is currently owned by insiders.
OrthoPediatrics Price Performance
KIDS traded up $0.83 on Friday, hitting $27.36. 117,648 shares of the company's stock traded hands, compared to its average volume of 120,081. The company's 50 day simple moving average is $28.07 and its 200-day simple moving average is $29.86. The firm has a market cap of $662.39 million, a price-to-earnings ratio of -25.10 and a beta of 1.16. OrthoPediatrics Corp. has a one year low of $24.02 and a one year high of $36.23. The company has a current ratio of 4.90, a quick ratio of 1.96 and a debt-to-equity ratio of 0.03.
OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last issued its quarterly earnings data on Monday, August 5th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.08. The business had revenue of $52.80 million for the quarter, compared to analysts' expectations of $52.40 million. OrthoPediatrics had a negative return on equity of 5.44% and a negative net margin of 14.35%. As a group, research analysts anticipate that OrthoPediatrics Corp. will post -0.92 EPS for the current year.
Analysts Set New Price Targets
Several brokerages have recently weighed in on KIDS. JMP Securities reiterated a "market outperform" rating and issued a $50.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th. Needham & Company LLC reiterated a "buy" rating and issued a $42.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th. Finally, Truist Financial reduced their price objective on OrthoPediatrics from $34.00 to $28.00 and set a "hold" rating for the company in a report on Monday, October 14th.
Get Our Latest Analysis on KIDS
About OrthoPediatrics
(
Free Report)
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Further Reading
Before you consider OrthoPediatrics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OrthoPediatrics wasn't on the list.
While OrthoPediatrics currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
